Comment of Vincenza Snow, senior medical associate in the ACP scientific policy department, on the importance of controlling cardiovascular risk factors; Evidence that the recommendations are based on; View of Nathaniel Clark, national vice president for clinical affairs for the American Diabetes ...
Is it possible for diabetics infected with HBV or HCV to reduce the risk of hepatocellular carcinoma by taking a statin? Objectives: To determine the relationship between the dose effect of Statin and the risk of HCC. Methods: This study was a case-control study. All particip... GF Chiu,...
Statin Recommendations for Primary Prevention JAMA Editorial August 23, 2022 Patient Information: Statins for the Prevention of Cardiovascular Disease JAMA JAMA Patient Page August 23, 2022 This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on using statins ...
SUGGESTED for you The percentage of patients with diabetes varied in these studies. The largest and most recent study comprised only diabetics. In the other studies, about 20% to 40% of the patients were diabetic. Overall Outcome Supports Preprocedure Statin Use The overall outcome was quite int...
Our study provides an updated epidemiological indication of possible errors in the CVD risk algorithms of many clinical guidelines. If our findings are generalizable, clinical and public health recommendations regarding the ‘dangers’ of cholesterol should be revised. This is especially true f...
[lowering their lipids], and I remind them that we have a very long list of medications that we may have to use, including some antidiabetic medications. Many people who are hypertriglyceridemic are "diabetics in training," as I call them, orinsulinresistant, so you may be able to use ...
As commented above, patients were grouped according to the dose of simvastatin during hospitalization. There was no significant difference across groups (both in the whole cohort and in non-diabetics) regarding clinical characteristics as well as infarction mass estimated by MRi, reperfusion therapy, ...
The variousmechanisms for this effect have been proposed and oneof them is downregulation of glucose transporters bythe statins. The recommendations by the investigatorsare that though statins can have diabetogenic risk,they have more long term benefits which can outweighthe risk. In elderly patients ...
Implementation of the ADA's statin recommendations increased over the study period. Statin use differed significantly by patients' risk status. Future ADA's Standards focusing on how to improve utilization of statins for individuals with different risk status, particularly those with CVD risk factors ...
BACKGROUND: Diabetes mellitus (DM), coronary artery disease (CAD), and noncoronary atherosclerotic vascular diseases (NCVDs) have similar risks of cardiovascular events and similar recommendations for lipid control. There are limited data regarding lipid control in diabetic patients with NCVD in ...